Otsuka Pharmaceutical Factory, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1969-10-07
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.otsukakj.jp
A Study to Investigate Safety and Effectiveness of Pancreatic Cells Derived From Pigs (OPF-310) in Patients With Type 1 Diabetes Mellitus
Phase 1
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 1Hypoglycemia
- Interventions
- Drug: OPF-310
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Otsuka Pharmaceutical Factory, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT06575426
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
Phase 1
Completed
- Conditions
- Obesity
- Interventions
- Drug: NO-13065Drug: Placebo
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Otsuka Pharmaceutical Factory, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT04838639
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath